Clinico-morphological features of braf inhibition-induced proliferative skin lesions in cancer patients.
Times cited: 8
Development of prediction tools for diarrhea and rash in breast cancer patients receiving lapatinib in combination with capecitabine.
Breast Cancer Research and Treatment.
Times cited: 9